Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSBS.L Regulatory News (SBS)

  • There is currently no data for SBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Source Bioscience Plc

10 Aug 2016 09:22

RNS Number : 7858G
Nplus1 Singer Capital Markets Ltd
10 August 2016
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED IN,TERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nplus1 Singer Capital Markets Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

 

Source Bioscience Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

 

Source Bioscience Plc

(d) Date dealing undertaken:

9 August 2016

 

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

Yes

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 2P

 

Purchase

 

404,922

 

17.85p

 

17.655p

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

Date of disclosure:

10 August 2016

Contact name:

Reema Maru

Telephone number:

020 7496 3094

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERAKKDBFBKKKFD
Date   Source Headline
17th Jun 201612:00 pmRNSForm 8 (OPD) Source BioScience plc
17th Jun 20169:42 amRNSForm 8.5 (EPT/RI)
16th Jun 20168:43 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
15th Jun 20169:06 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
14th Jun 20168:49 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
13th Jun 20169:21 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
10th Jun 20168:56 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
9th Jun 20164:03 pmRNSResult of AGM
9th Jun 20163:12 pmRNSForm 8.3 - Source BioScience plc
9th Jun 20169:05 amRNSAGM Statement
9th Jun 20168:45 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
8th Jun 20169:24 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
7th Jun 20162:02 pmRNSForm 8.3 - Source BioScience plc
7th Jun 201611:05 amRNSHolding(s) in Company
7th Jun 20169:01 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
6th Jun 20164:00 pmRNSForm 8 (OPD) offeror - Source Bioscience plc
6th Jun 20161:57 pmRNSForm 8.3 - Source BioScience plc
6th Jun 201611:50 amBUSForm 8.3 - Source Bioscience Plc
6th Jun 201611:29 amRNSForm 8.3 - Source BioScience Plc
6th Jun 201610:22 amRNSForm 8.5 (EPT/RI) - Source Bioscience Plc
3rd Jun 20162:45 pmRNSForm 8.3 - Source BioScience Plc
3rd Jun 20167:30 amRNSResponse to statement
3rd Jun 20167:00 amRNSStatement re Possible Offer for Source BioScience
12th May 20164:50 pmRNSNotice of AGM
22nd Mar 20167:00 amRNSFinal Results
9th Mar 20163:55 pmRNSNotice of Results
22nd Feb 201611:06 amRNSHolding(s) in Company
8th Feb 201610:31 amRNSHolding(s) in Company
29th Jan 20167:00 amRNSTrading Statement
22nd Jan 201610:00 amRNSHolding(s) in Company
22nd Dec 201510:23 amRNSHolding(s) in Company
2nd Dec 20157:00 amRNSExpansion of online diagnostic testing service
30th Nov 20153:04 pmRNSTotal Voting Rights
24th Nov 201511:17 amRNSHolding(s) in Company
24th Nov 201511:10 amRNSHolding(s) in Company
23rd Nov 201510:09 amRNSHolding(s) in Company
19th Nov 201510:02 amRNSAdditional Listing
12th Nov 201510:18 amRNSHolding(s) in Company
12th Nov 201510:14 amRNSHolding(s) in Company
12th Nov 201510:09 amRNSHolding(s) in Company
5th Nov 201510:27 amRNSHolding(s) in Company
5th Nov 201510:15 amRNSHolding(s) in Company
4th Nov 201510:41 amRNSHolding(s) in Company
2nd Nov 20153:17 pmRNSAdditional Listing
2nd Nov 201510:38 amRNSHolding(s) in Company
14th Oct 201510:09 amRNSHolding(s) in Company
14th Oct 20159:54 amRNSDirector/PDMR Shareholding
5th Oct 201510:20 amRNSAdditional Listing
30th Sep 20153:37 pmRNSTotal Voting Rights
30th Sep 20153:28 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.